TFF2 and gastritis: The role of these peptidergic afferents depends on the experimental paradigm and the consequent pathophysiological mechanisms—they can both inhibit (e.g., ethanol-induced gastritis) or aggravate the inflammation presumably via SP and CGRP release (e.g., IAA-induced gastritis), underlining the role of neurogenic component in inflammation [47].